Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency

Pediatrics

Volumn 120, Issue 1, 2007, Pages

  Maguire, Ann M ^a,b   Ambler, Geoffrey R ^a,b   Moore, Bin ^a   McLean, Mark ^c,d   Falleti, Marina G ^e   Cowell, Christopher T ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e Scientific Division   (Australia)

Author keywords

Adrenal insufficiency; Dosing; Hydrocortisone; Hypocortisolemia

Indexed keywords

HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; DOSAGE SCHEDULE COMPARISON; DOSE TIME EFFECT RELATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOPITUITARISM; LETHARGY; MALE; PRESCRIPTION; PRIORITY JOURNAL; WAKEFULNESS;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; MALE; PSYCHOMOTOR PERFORMANCE;

EID: 34447128712     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-2558     Document Type: Article

References (21)

1. Kenny FM, Preeyasombat C, Migeon CJ. Cortisol production rate: II. Normal infants, children, and adults. Pediatrics. 1966;37:34-42
2. Esteban NV, Loughlin T, Yergey AL et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab. 1991;72:39-45
3. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab. 1993;76:1505-1510
4. Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F. Cortisol production rate in childhood and adolescence. J Pediatr. 1990;117:892-896
5. Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol. 2001;169:65-70
6. Derendorf H, Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M. Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol. 1991;31:473-476
7. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 1992;340:1188-1192
8. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf). 1997;46:75-81
9. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285-288
10. Peacey SR, Guo CY, Robinson AM et al. Glucocorticoid replacement therapy: are patients over treated and does it matter. Clin Endocrinol (Oxf). 1997;46:255-261
11. al Shoumer KA, Beshyah SA, Niththyananthan R, Johnston DG. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. Clin Endocrinol (Oxf). 1995;42:85-90
12. McConnell EM, Bell PM, Ennis C, et al. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism. Clin Endocrinol (Oxf). 2002;56:195-201
13. DeVile CJ, Stanhope R. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clin Endocrinol (Oxf). 1997;47:37-41
14. Sieratzki JS, Gompels C, Poyser K, Beaman J, Savage DC. Filter paper cortisol profiles in secondary adrenocortical insufficiency. Arch Dis Child. 1995;73:351-353
15. Groves RW, Toms GC, Houghton BJ, Monson JP. Corticosteroid replacement therapy: twice or thrice daily? J R Soc Med. 1988;81:514-516
16. Mollica CM, Maruff P, Collie A, Vance A. Repeated assessment of cognition in children and the measurement of performance change. Child Neuropsychology. 2005;11:303-310
17. Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf). 2005;63:483-492
18. Plat L, Leproult R, L'Hermite-Baleriaux M, et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab. 1999;84:3082-3092
19. de Lacerda L, Kowarski A, Migeon CJ. Diurnal variation of the metabolic clearance rate of cortisol. Effect on measurement of cortisol production rate. J Clin Endocrinol Metab. 1973;36:1043-1049
20. Merke DP, Cho D, Anton Calis K, Keil MF, Chrousos GP. Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86:441-445
21. Ross RJM. Optimization of adrenal glucocorticoid replacement therapy [abstract]. Presented at: annual meeting of the Endocrine Society; June 24-27, 2006; Boston, MA